Sanofi reaches deal on terms of sale of consumer health arm, say …
13 hours ago · SNY. PARIS (Reuters) -Sanofi on Sunday reached an agreement on terms to sell a controlling stake in its consumer health unit Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R ...
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions …
2 hours ago · Sanofi 2024 business EPS guidance upgraded today. Paris, October 21, 2024. Sanofi and CD&R announce today a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global ...
Sanofi enters exclusive talks with CD&R for Opella sale
2 hours ago · The French pharmceutical company said its Opella business has been valued at around 16 billion euros ($17.38 billion), or 14 times EBITDA in 2024, and French public investment bank Bpifrance is ...
Sanofi enters exclusive talks with CD&R for Opella sale - Yahoo …
2 hours ago · Sanofi said on Monday it had entered exclusive negotiations for the sale of a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R ...
Sanofi Enters Exclusive Talks With CD&R Over Opella Stake Sale
2 hours ago · Sanofi SAN -0.20% entered into exclusive talks to sell its consumer-healthcare business Opella to Clayton Dubilier & Rice in a deal that values the business as a whole at 16 billion euros ($17.39 ...
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI | Reuters
13 hours ago · The plan for Public Investment Bank (BPI) to take a 1% stake in Opella, for about 150 million euros ($162.98 million), came through a tri-party agreement between Sanofi, the French state and CD&R ...
Sanofi 'surprised' by PAI Partners' raised bid for Opella unit
3 days ago · The source told Reuters that the PAI-led consortium had hiked its bid by 200 million euros ($217.2 million) in a revised offer sent earlier on Thursday to Sanofi Chairman Frederic Oudea. It said ...
Press Release: Sanofi in discussions to sell a controlling stake in Opella
Paris, October 11, 2024. Sanofi today announces that the company has entered into negotiations with CD&R for the potential sale of a 50% controlling stake in Opella, its consumer healthcare business. Should these discussions lead to a positive outcome, any agreement would be subject to the completion of the necessary social processes.
Sanofi in talks to sell stake in consumer healthcare unit to CD&R
6 days ago · Sanofi has announced negotiations with Clayton Dubilier & Rice (CD&R), a US-based investment company, regarding the potential sale of a 50% controlling stake in its consumer healthcare business, Opella. The move marks a significant step in the company’s ongoing effort to sharpen its focus on its core areas of innovative medicines and vaccines.
Press Release: Sanofi in discussions to sell a controlling stake in Opella
Oct 11, 2024 · Sanofi in discussions to sell a controlling stake in Opella. Paris, October 11, 2024. Sanofi today announces that the company has entered into negotiations with CD&R for the potential sale of a 50 ...
- Some results have been removed